Literature DB >> 22282366

Long-term administration of m-chlorophenylpiperazine to rats does not alter functional sensitivity of either pre-synaptic or postsynaptic 5-HT1A receptors.

C S Aulakh1, J L Hill, T J Tolliver, D Marcantonio, D L Murphy.   

Abstract

Administration of the selective 5-HT(1A) agonist, 8-hydroxy-2(di-n-propylamino)tetralin (8-OHDPAT ), to rats produced increases in food intake in freely fed animals and decreases in food intake in food-deprived animals. Acute pre-treatment with various doses of m-chlorophenylpiperazine (m-CPP, another 5-HT agonist) attenuated 8-OHDPAT-induced increases in food intake in the free-feeding paradigm and enhanced 8- OHDPAT-induced decreases in food intake in the food-deprived paradigm. In the two paradigms, however, neither increases nor decreases in food intake induced by 8-OHDPAT were altered in animals following long- term (21-day) treatment with m-CPP versus saline when animals were challenged with 8-OHDPAT 48 h after the last dose of m-CPP. These findings suggest that long-term m-CPP treatment does not alter the functional sensitivity of 5-HT(1A) receptors located pre-synaptically that mediate hyperphagia or 5-HT(1A) receptors located post-synaptically that mediate decreases in food intake by induction of the serotonin behavioural syndrome.

Entities:  

Year:  1991        PMID: 22282366     DOI: 10.1177/026988119100500208

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  2 in total

1.  Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effects.

Authors:  J Benjamin; B D Greenberg; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.

Authors:  A J Kennedy; E L Gibson; M T O'Connell; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.